Last week, I was contemplating my recent ETF options trading performance because it seemed less satisfactory than my prior year’s performance. I was still feeling pretty good because of locking in $65,000 in ETF trading profits over the past 30 days, but that winning run followed what I thought was a dismal January/February. Instead of […]
Many new and experienced swing traders make the mistake of focusing only on short-term daily charts when scanning for new trading opportunities. While daily charts are great for locating low-risk entry points, the limited price history is not very useful when narrowing down a list of potential buy candidates. This is where long-term monthly stock […]
Most of the articles on this trading blog focus on how to trade technical chart patterns such as the cup and handle. We’ve also penned mini-lessons on various topics, such as trading psychology, to help improve your swing trading success. But one thing we do not often discuss on the Morpheus blog is candlestick charts. […]
2017 was a stellar year for the stock market, but an inevitable correction started to hit the market at the end of January. Here is our “no nonsense” technical analysis for what may be coming next. With its best year since 2013, the benchmark S&P 500 Index jumped 19% in 2017. The S&P 500 then […]
We recently bought Union Pacific ($UNP) as a breakout trade, held it for ten weeks, then sold for a +20% gain ahead of earnings. Continue reading to find out why we picked this stock for buy entry, and how we managed this trade for maximum profitability with low risk. The chart pattern of transportation stock […]
Two days ago, we notified you in this post of Dr. Jack’s swing trade buy entry into $EEM and $EEM call options. Since I promised the trade would be tracked in real-time, here is a quick follow-up on the trade (hint: It’s boring, but winning). Dr. Jack Loftis November 16, 2017 Doubled down on EDC […]
We recently bought Mazor Robotics ($MZOR) as a breakout trade, held it for two months, then sold for a gain of +57.6%. Continue reading to find out why we picked this stock for buy entry, and how we determined when to sell for maximum profit. Israeli medical device manufacturer Mazor Robotics ($MZOR) first caught our attention […]